Stockreport

Aimmune's peanut allergy drug meets main goal, shares surge [Reuters]

AIMMUNE THERAPEUTICS  (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile
PDF Aimmune's peanut allergy drug meets main goal, shares surge | Reuters 2 Min Read (Reuters) - U.S. drug developer Aimmune Therapeutics Inc said on Tuesday its peanut alle [Read more]